To transcriptionally and serologically profile blood from COVID-19 patients to determine the molecular signatures associated with a spectrum of disease severities. These studies will expand our knowledge of COVID-19 pathogenesis and biomarkers of disease.
- Funded by Emergent Ventures Fast Grants
- Total publications:0 publications
Grant number: unknown
Grant search
Key facts
Disease
COVID-19start year
-99Known Financial Commitments (USD)
$0Funder
Emergent Ventures Fast GrantsPrincipal Investigator
Dr. Timothy SheahanResearch Location
United States of AmericaLead Research Institution
University of North CarolinaResearch Priority Alignment
N/A
Research Category
Pathogen: natural history, transmission and diagnostics
Research Subcategory
Pathogen morphology, shedding & natural history
Special Interest Tags
N/A
Study Type
Unspecified
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Unspecified
Vulnerable Population
Unspecified
Occupations of Interest
Unspecified